Digital pathology

This histological-based assessment revealed that lymphocytes that are infiltrating tumors as a substitute for responses linked to host immunity are being shown to be predictive and possibly chemopredictive in triple-negative and HER2-positive breast cancers. However, the cooperation of the mentioned lymphocytes, mediators, tumor cells, micro environmental characteristics, their number and associations are still to be explored. It is envisaged that a tool called digital pathology will be used to assess these targeted resources and chemotherapeutic reactions in the patient. Based on digital pathology, an image analysis algorithm is being developed to recognize lymphocytes, stromal and neoplastic cells, in addition to obtaining an image of the slides stained with H&E.

    Related Conference of Digital pathology

    July 11-12, 2022

    Global Pathologists Meet

    Osaka, Japan
    July 18-19, 2022

    20th Asia Pacific Pathology Congress

    Brisbane, Australia
    July 18-19, 2022

    3rd World Congress on Histopathology & Cytopathology

    Brisbane, Australia
    September 05-06, 2022

    World Congress on Pathology and Microbiology

    Osaka, Japan
    September 15-16, 2022

    3rd International Conference on Breast Pathology and Cancer Diagnosis

    Prague, Czech Republic
    September 19-20, 2022

    4th World Congress on Pathology and Clinical Practice

    Rome, Italy
    September 22-23, 2022

    20th European Pathology Congress

    Paris, France
    October 10-11, 2022

    Birth Congress 2022

    Vancouver, Canada
    December 12-13, 2022

    19th Annual Conference on Laboratory Medicine and Pathology

    Prague, Czech Republic

    Digital pathology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in